Cargando…
Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial
BACKGROUND: Patent ductus arteriosus (PDA) is one of most common complications in preterm infants. Although ibuprofen represents the first choice for the closure of PDA, this treatment can cause severe gastrointestinal and adverse renal effects and worsen platelet function. The successful closure of...
Autores principales: | Dani, Carlo, Poggi, Chiara, Mosca, Fabio, Schena, Federico, Lista, Gianluca, Ramenghi, Luca, Romagnoli, Costantino, Salvatori, Enrica, Rosignoli, Maria Teresa, Lipone, Paola, Comandini, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818852/ https://www.ncbi.nlm.nih.gov/pubmed/27038924 http://dx.doi.org/10.1186/s13063-016-1294-4 |
Ejemplares similares
-
Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
por: Dani, Carlo, et al.
Publicado: (2020) -
Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017) -
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates
por: Terrin, Gianluca, et al.
Publicado: (2014) -
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020) -
Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment
por: Yoo, Hani, et al.
Publicado: (2017)